The government has sought the competition authority's views after Flipkart's Big Billion Day Diwali sale but trends in global regulation suggest that despite traditional retailers' objections, online
'Pay-for-delay' settlements between drug patent-holders and generics manufacturers to delay the launch of cheaper generic medicine are increasingly being scrutinised by antitrust regulators
 "Vaibhav Choukse")
